LIMD2 is a Prognostic and Predictive Marker in Patients With Esophageal Cancer Based on a ceRNA Network Analysis

Globally, esophageal cancer (ECA) is the seventh most common cancer and sixth most common cause of cancer-associated mortality. However, there are no reliable prognostic and predictive molecular markers for ECA; in addition, the pathogenesis of ECA is not fully elucidated. The expressions of circula...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yuanmei Chen, Xinyi Huang, Kunshou Zhu, Changkun Li, Haiyan Peng, Lin Chen, Zhengrong Huang, Yangfan Zhang, Guibin Weng, Tianya Xiao, Junqiang Chen, Yuanji Xu
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/5322fa70e0aa437284eb17129d83d503
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5322fa70e0aa437284eb17129d83d503
record_format dspace
spelling oai:doaj.org-article:5322fa70e0aa437284eb17129d83d5032021-11-18T06:06:18ZLIMD2 is a Prognostic and Predictive Marker in Patients With Esophageal Cancer Based on a ceRNA Network Analysis1664-802110.3389/fgene.2021.774432https://doaj.org/article/5322fa70e0aa437284eb17129d83d5032021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fgene.2021.774432/fullhttps://doaj.org/toc/1664-8021Globally, esophageal cancer (ECA) is the seventh most common cancer and sixth most common cause of cancer-associated mortality. However, there are no reliable prognostic and predictive molecular markers for ECA; in addition, the pathogenesis of ECA is not fully elucidated. The expressions of circular RNAs (circRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs) of ECA and control groups were obtained from the RNA-sequencing (RNA-seq) data of our hospital, the Gene Expression Omnibus (GEO), and The Cancer Genome Atlas (TCGA) datasets. Analyses of differentially expressed genes, the circRNA–miRNA–mRNA–competing endogenous RNA (ceRNA) network, and functional/pathway enrichment were conducted. The key targets in the ceRNA network that showed significant results in survival Cox regression analyses were selected. Furthermore, analyses of immune infiltration and autophagy genes related to the key targets were performed. Seven circRNAs, 22 miRNAs, and 34 mRNAs were identified as vital genes in ECA; the nuclear factor-κ-gene binding (NF-κB) and phosphatidylinositol-3 kinase/protein kinase B (PI3K-Akt) signaling were identified as the most enriched pathways. In addition, the LIM domain containing 2 (LIMD2) was an independent predictor of prognosis in ECA patients and closely associated with immunity and autophagy. Moreover, quantitative reverse-transcription polymerase chain reaction (qRT-PCR) revealed significant upregulation of LIMD2 expression in ECA tissues. ECA may be closely correlated with NF-κB and PI3K/Akt signaling. In addition, LIMD2 could be a potential prognostic and predictive marker of ECA.Yuanmei ChenXinyi HuangKunshou ZhuChangkun LiHaiyan PengLin ChenZhengrong HuangYangfan ZhangGuibin WengTianya XiaoJunqiang ChenYuanji XuFrontiers Media S.A.articleesophageal cancercompeting endogenous RNALIM domain containingprognosticpredictiveGeneticsQH426-470ENFrontiers in Genetics, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic esophageal cancer
competing endogenous RNA
LIM domain containing
prognostic
predictive
Genetics
QH426-470
spellingShingle esophageal cancer
competing endogenous RNA
LIM domain containing
prognostic
predictive
Genetics
QH426-470
Yuanmei Chen
Xinyi Huang
Kunshou Zhu
Changkun Li
Haiyan Peng
Lin Chen
Zhengrong Huang
Yangfan Zhang
Guibin Weng
Tianya Xiao
Junqiang Chen
Yuanji Xu
LIMD2 is a Prognostic and Predictive Marker in Patients With Esophageal Cancer Based on a ceRNA Network Analysis
description Globally, esophageal cancer (ECA) is the seventh most common cancer and sixth most common cause of cancer-associated mortality. However, there are no reliable prognostic and predictive molecular markers for ECA; in addition, the pathogenesis of ECA is not fully elucidated. The expressions of circular RNAs (circRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs) of ECA and control groups were obtained from the RNA-sequencing (RNA-seq) data of our hospital, the Gene Expression Omnibus (GEO), and The Cancer Genome Atlas (TCGA) datasets. Analyses of differentially expressed genes, the circRNA–miRNA–mRNA–competing endogenous RNA (ceRNA) network, and functional/pathway enrichment were conducted. The key targets in the ceRNA network that showed significant results in survival Cox regression analyses were selected. Furthermore, analyses of immune infiltration and autophagy genes related to the key targets were performed. Seven circRNAs, 22 miRNAs, and 34 mRNAs were identified as vital genes in ECA; the nuclear factor-κ-gene binding (NF-κB) and phosphatidylinositol-3 kinase/protein kinase B (PI3K-Akt) signaling were identified as the most enriched pathways. In addition, the LIM domain containing 2 (LIMD2) was an independent predictor of prognosis in ECA patients and closely associated with immunity and autophagy. Moreover, quantitative reverse-transcription polymerase chain reaction (qRT-PCR) revealed significant upregulation of LIMD2 expression in ECA tissues. ECA may be closely correlated with NF-κB and PI3K/Akt signaling. In addition, LIMD2 could be a potential prognostic and predictive marker of ECA.
format article
author Yuanmei Chen
Xinyi Huang
Kunshou Zhu
Changkun Li
Haiyan Peng
Lin Chen
Zhengrong Huang
Yangfan Zhang
Guibin Weng
Tianya Xiao
Junqiang Chen
Yuanji Xu
author_facet Yuanmei Chen
Xinyi Huang
Kunshou Zhu
Changkun Li
Haiyan Peng
Lin Chen
Zhengrong Huang
Yangfan Zhang
Guibin Weng
Tianya Xiao
Junqiang Chen
Yuanji Xu
author_sort Yuanmei Chen
title LIMD2 is a Prognostic and Predictive Marker in Patients With Esophageal Cancer Based on a ceRNA Network Analysis
title_short LIMD2 is a Prognostic and Predictive Marker in Patients With Esophageal Cancer Based on a ceRNA Network Analysis
title_full LIMD2 is a Prognostic and Predictive Marker in Patients With Esophageal Cancer Based on a ceRNA Network Analysis
title_fullStr LIMD2 is a Prognostic and Predictive Marker in Patients With Esophageal Cancer Based on a ceRNA Network Analysis
title_full_unstemmed LIMD2 is a Prognostic and Predictive Marker in Patients With Esophageal Cancer Based on a ceRNA Network Analysis
title_sort limd2 is a prognostic and predictive marker in patients with esophageal cancer based on a cerna network analysis
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/5322fa70e0aa437284eb17129d83d503
work_keys_str_mv AT yuanmeichen limd2isaprognosticandpredictivemarkerinpatientswithesophagealcancerbasedonacernanetworkanalysis
AT xinyihuang limd2isaprognosticandpredictivemarkerinpatientswithesophagealcancerbasedonacernanetworkanalysis
AT kunshouzhu limd2isaprognosticandpredictivemarkerinpatientswithesophagealcancerbasedonacernanetworkanalysis
AT changkunli limd2isaprognosticandpredictivemarkerinpatientswithesophagealcancerbasedonacernanetworkanalysis
AT haiyanpeng limd2isaprognosticandpredictivemarkerinpatientswithesophagealcancerbasedonacernanetworkanalysis
AT linchen limd2isaprognosticandpredictivemarkerinpatientswithesophagealcancerbasedonacernanetworkanalysis
AT zhengronghuang limd2isaprognosticandpredictivemarkerinpatientswithesophagealcancerbasedonacernanetworkanalysis
AT yangfanzhang limd2isaprognosticandpredictivemarkerinpatientswithesophagealcancerbasedonacernanetworkanalysis
AT guibinweng limd2isaprognosticandpredictivemarkerinpatientswithesophagealcancerbasedonacernanetworkanalysis
AT tianyaxiao limd2isaprognosticandpredictivemarkerinpatientswithesophagealcancerbasedonacernanetworkanalysis
AT junqiangchen limd2isaprognosticandpredictivemarkerinpatientswithesophagealcancerbasedonacernanetworkanalysis
AT yuanjixu limd2isaprognosticandpredictivemarkerinpatientswithesophagealcancerbasedonacernanetworkanalysis
_version_ 1718424537578602496